AbbVie — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Leal Therapeuticslealtx.comSeries A · Oct 2024 · $45M
Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.
BiotechHealthtechMedical DevicesWorcester, US
Asa Abeliovich(CEO & Founder, Director)
Co-investorsOrbiMedSV Health InvestorsDementia Discovery FundNewpath Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


